cerrar
Tagged with USA

ICER Strikes Again: Scandal Time?
The US drug-price watchdog, The Institute for Clinical & Economic Review (ICER) recently issued a “Report on Unsupported Price Increases“,…

Four Top US Investments in UAE Healthcare
The UAE is putting a greater emphasis on healthcare than ever before as part of its ‘Vision 2021’ model. With the aim of being "flexible in…

The Sea Turtles: China’s Top Pharma Talent Comes Home
The meteoric growth of the pharmaceutical industry in China in recent years has seen a host of top Chinese talent return home from studying and…

US FDA CBD Approvals Set to Soar
Sophia Ononye outlines the history of cannabis as a medicine in the US and, following the first FDA approval of a cannabis-derived drug product in…

New York: A Biotech Hub to Rival Boston & California?
Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong…

The Three Top Political Issues for Big Pharma
Eurasia Group’s Aditya Bhattacharji and Sarah Hassan identify and unpack the top three political and policy issues that multinational pharmaceutical…

Jennifer Hawks Bland – CEO, NewYorkBIO, USA
Jennifer Hawks Bland of NewYorkBIO, the premier trade association for the life sciences in New York State, discusses the association’s diverse list…

From Hype to Health: Delivering on the Promise of AI in Biopharma
Krishna Cheriath, chief data officer at BMS, outlines the ways in which AI is already transforming the delivery of healthcare, what modern biopharma…

5 Ways to Achieve a Sustainable US Health System
In the face of rising costs in American healthcare, Carla Smith outlines five ways in which the US can improve the financial sustainability of its…

How US Healthcare Can Better Accommodate Cell & Gene…
PhRMA's Anne McDonald Pritchett PhD highlights the remarkable development of cell and gene therapies in recent years and the three ways in which the…

The USA’s Safe Importation Action Plan: Trump’s Pharma…
In a bid to make tangible progress on the issue of lowering prescription drug pricing before the 2020 presidential election, the Trump administration…

US Pharma Could do a Lot More to Embrace the Consumer
PwC's Kelly Barnes examines how the US pharmaceutical sector is having to rethink its relationship with consumers, experimenting with new and…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here